Financials
Value Q1, 25Q2, 25Q3, 25Q4, 25Q1, 26 TTM Selling/general/admin expenses 283.6 M318.05 M303.22 M349.12 M314.81 M 1.29 B Research & development 268.12 M276.66 M286.46 M294.98 M295.82 M 1.15 B Operating income 332.82 M472.3 M456.8 M614.15 M431.67 M 1.97 B Non-Operating Income, Total 56.25 M7.96 M53.02 M21.23 M40.86 M 123.07 M Interest expense, net of interest capitalized ————— — Non-Operating Income, excl. Interest Expenses 55.27 M8.21 M52.42 M20.82 M39.1 M 120.55 M Unusual income/expense 987 K-256 K598 K409 K1.77 M 2.52 M Pretax income 389.08 M480.25 M509.82 M635.39 M472.53 M 2.1 B Equity in earnings ————— — Taxes 56.31 M79.43 M108.2 M106.7 M67.45 M 361.79 M Non-controlling/minority interest ————— — After tax other income/expense ————— — Net income before discontinued operations 332.77 M400.82 M401.62 M528.68 M405.08 M 1.74 B Discontinued operations ————— — Net income 332.77 M400.82 M401.62 M528.68 M405.08 M 1.74 B Dilution adjustment ————— — Preferred dividends ————— — Diluted net income available to common stockholders 332.77 M400.82 M401.62 M528.68 M405.08 M 1.74 B Basic earnings per share (Basic EPS) 1.732.082.092.752.1 9.02 Diluted earnings per share (Diluted EPS) 1.722.072.082.722.09 8.96 Average basic shares outstanding 192.54 M192.52 M192.46 M192.47 M192.67 M — Diluted shares outstanding 193.72 M193.42 M193.53 M193.62 M193.56 M — EBITDA 379.12 M519.4 M505.91 M660.41 M480.79 M 2.17 B EBIT 332.82 M472.3 M456.8 M614.15 M431.67 M 1.97 B Cost of revenue 650.55 M747.55 M724.41 M866.7 M711.2 M 3.05 B Other cost of goods sold ————— — Depreciation & amortization (cash flow) 46.3 M47.1 M49.1 M46.25 M49.13 M 191.59 M